Injection, USP solution prior to infusion. The line must be flushed with sterile 0.9% Sodium Chloride A pre-existing intravenous line may be used for administration.Bolus injection by injecting both vials consecutively oneĪfter another via syringe (see Figure 3).Two consecutive infusions (see Figure 2) or.Intravenously administer the dose of 5 g (2 vials, each.Do not mix with other medicinal products.

May be stored at room temperature, 25☌ (77☏), but must be used withinĦ hours. Vial, administration should begin promptly. Particulate matter and discoloration prior to administration, whenever Parenteral drug products should be inspected visually for.Ensure aseptic handling when preparing the infusion. Remove both vials (each containing 2.5 g/50 mL idarucizumab) from carton.

There is limited data to support administration of an additional 5 g of PRAXBIND. Both vials are packaged together in one carton. The recommended dose of PRAXBIND is 5 g, provided as two separate vials each containing 2.5 g/50 mL idarucizumab (see Figure 1).

In life-threatening or uncontrolled bleedingĢ DOSAGE AND ADMINISTRATION 2.1 Recommended Dose.

For emergency surgery/urgent procedures.

Pradaxa when reversal of the anticoagulant effects of dabigatran is PRAXBIND is indicated in patients treated with

Pradaxa praxbind